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E ssential oils are volatile organic compounds extracted from plants.  The essential oil from lav-
ender,  i.e.,  Lavandula angustifolia (Lvn) is one of the 
most common essential oils.  As some clinical trials 
report,  Lvn is useful for improving health and alleviat-
ing anxiety [1],  insomnia [2],  depression [3],  and pain 
[4].  In animal experiments,  Lvn exhibited anti-bacte-
rial and anti-inflammatory effects [5 , 6].  We reported 
that Lvn suppressed the allergic inflammations in an 
ovalbumin (OVA)-sensitized murine model of asthma 
[7].  Lvn treatment reduced the infiltration of inflam-
matory cells such as macrophages,  eosinophils,  and 
lymphocytes into bronchoalveolar lavage fluid,  peri-
bronchial tissues,  and perivascular tissues in the lungs 
in a murine model of asthma [7].
The essential oils include dozens of constituents at 
different concentrations,  and generally two or three 
main constituents characterize the essential oils’ biolog-
ical properties [8].  The main constituents of Lvn are 
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Lavender essential oil (Lvn) has anti-inflammatory effects in an ovalbumin-sensitized murine model of asthma,  
and inhibits inflammatory cell infiltration into the lungs.  The anti-inflammatory effects of Lvn on cell adhesion 
molecules are not clear.  Here we evaluated the effects of Lvn and its main constituents,  linalyl acetate (LA) and 
linalool (LO),  on the expression of tumor necrosis factor-alpha (TNF-α)-induced cell adhesion molecules in 
murine brain endothelial bEnd.3 cells and human umbilical vein endothelial cells (HUVECs).  The bEnd.3 cells 
were treated with Lvn,  LA,  or LO and subsequently stimulated with TNF-α.  The mRNA expression levels of cell 
adhesion molecules were detected using RT-PCR.  E-selectin and P-selectin protein and phosphorylated-NF-κB 
p65 were detected by western blotting.  The effects of Lvn on HUVECs were measured by RT-PCR.  In bEnd.3 
cells,  Lvn and LA suppressed TNF-α-induced E-selectin,  P-selectin,  vascular cell adhesion molecule-1,  inter-
cellular adhesion molecule-1,  and phosphorylated-NF-κB p65 in the nucleus; LO did not suppress P-selectin or 
phosphorylated-NF-κB p65.  Lvn inhibited TNF-α-induced E-selectin mRNA in HUVECs.  These results indi-
cate that Lvn and LA inhibit TNF-α-induced cell adhesion molecules in endothelial cells through the suppres-
sion of NF-κB activation.  Consequently,  Lvn or other essential oils including LA may be useful as alternative 
anti-inflammatory medicines.
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monoterpenes,  such as linalyl acetate (LA) and linalool 
(LO) [9].  LA and LO showed anti-inflammatory effects 
in carrageenan-induced edema in rats [10].  LA and LO 
also inhibited nuclear factor-kappa B (NF-κB) activa-
tion in the human cervical adenocarcinoma cell line 
Hela and the murine macrophage cell line RAW264.7 
cells,  respectively [11 , 12].  NF-κB is a transcription 
factor that induces the production of cell adhesion mol-
ecules such as E-selectin,  P-selectin,  vascular cell 
adhesion molecule-1 (VCAM-1),  and intercellular 
adhesion molecule-1 (ICAM-1) [13 , 14].  These cell 
adhesion molecules are involved in the infiltration of 
leukocytes and the pathogenesis of asthma [15-18].  In a 
murine model of asthma,  asthmatic symptoms were 
suppressed by the inhibition of the NF-κB signaling 
pathway [19 , 20].  In our murine model of asthma,  Lvn 
treatment reduced the infiltration of inflammatory cells 
into the lungs [7].
These observations led us to hypothesize that the 
expression of cell adhesion molecules could be sup-
pressed by Lvn treatment in vascular endothelial cells 
through the inhibition of NF-κB activation.  We specu-
lated that the main constituents of Lvn,  such as LA and 
LO,  might be involved in those effects.  In the present 
study we used murine brain endothelial cell line bEnd.3 
cells,  which have frequently been used to study cell 
adhesion molecules in inflammation [13].  To extrapo-
late the anti-inflammatory effects of Lvn on the human 
body,  we also used human umbilical vein endothelial 
cells (HUVECs).  We examined the effects of Lvn,  LA,  
and LO on the variations of tumor necrosis factor-alpha 
(TNF-α)-induced cell adhesion molecules in endothe-
lial cells.
Materials and Methods
Reagents. The essential oil from Lavandula 
angustifolia (Lvn) was obtained from ROHTO Phar-
maceutical (Osaka,  Japan).  The reagents’ certificate of 
gas chromatography mass spectrometry analysis was 
supplied by ROHTO.  The main constituents of the Lvn 
essential oil were as follows: linalyl acetate (LA) 34.65%,  
linalool (LO) 26.99%,  β-caryophyllene 4.86%,  trans-β-
ocimene 4.63%,  lavandulyl acetate 4.36%,  cis-β-
ocimene 2.89%,  and terpinene-4-ol 2.89%; other con-
stituents were < 2%.  The specific gravity was 0.883 and 
the refractive index was 1.461.
LA was obtained from Wako Pure Chemical Indus-
tries (Osaka,  Japan).  LO was obtained from Tokyo 
Chemical Industry (Tokyo,  Japan).  The murine TNF-α 
and human TNF-α were purchased from Roche Applied 
Science (Penzberg,  Bavaria,  Germany).
Cell culture. The bEnd.3 cells,  a murine brain 
endothelioma cell line,  were obtained from the 
American Type Culture Collection (ATCC; Manassas,  
VA,  USA).  The bEnd.3 cells were grown in Dulbecco’s 
modified Eagle medium (DMEM) (Sigma Chemicals,  
St. Louis,  MO,  USA) supplemented with 10% fetal 
bovine serum (Life Technologies,  Carlsbad,  CA,  USA) 
and 1% penicillin-streptomycin (Life Technologies) at 
37°C in an atmosphere of 5% CO2.
HUVECs were obtained from PromoCell 
(Heidelberg,  Germany) and grown in Endothelial Cell 
Growth Medium 2 (PromoCell) at 37°C in an atmo-
sphere of 5% CO2.  Sub-confluent,  proliferating 
HUVECs at passages 2-5 were used.
Treatment of bEnd.3 cells and HUVECs with Lvn, 
LA,  and LO,  followed by TNF-α stimulation. The 
bEnd.3 cells were incubated for 2 h in the absence or 
presence of Lvn at one of two concentrations (0.01% or 
0.005%).  We confirmed that these concentrations of 
Lvn did not exhibit cytotoxicity by conducting an MTT 
assay (data not shown).  The incubation time was deter-
mined by preliminary experiments with reference to 
Spelman et al.  [21].  Lvn was diluted in dimethyl sulfox-
ide (DMSO) (Sigma Chemicals).  To obtain consistent 
final concentrations of DMSO,  all of the media were 
0.09% DMSO.  Subsequently,  the cells were incubated 
without or with murine TNF-α (250 U/mL).  The cul-
tures intended for total RNA extraction were incubated 
for 3 h,  and those intended for protein extraction were 
incubated for 5 h.  These incubation times were deter-
mined by preliminary experiments with reference to 
previous reports [13 , 22].
To assay the effects of LA and LO on the expression 
of cell adhesion molecules,  we repeated this Lvn work-
flow,  substituting LA or LO for Lvn.  HUVECs were 
incubated in the absence or presence of one of two Lvn 
concentrations (0.01% or 0.005%) for 2 h.  The cells 
were incubated without or with human TNF-α (100 U/
mL) for 3 h to extract total RNA.  Equal volumes of 
phosphate buffered-saline (PBS) were added to 
non-stimulated cells.
Reverse transcription-polymerase chain reaction 
(RT-PCR) for cell adhesion molecules. After the cul-
ture medium was removed,  the cells were washed with 
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ice-cold PBS.  We then extracted the total RNA using 
TRIzol® (Life Technologies) according to the manufac-
turer’s protocol.  Complementary DNA (cDNA) was 
synthesized from 1 μg RNA with random hexamer 
primers from a Transcriptor First Strand cDNA Synthe-
sis Kit (Roche Diagnostics,  Mannheim,  Germany).  
PCR amplifications were performed using a fixed 
amount of cDNA (1 μL),  a pair of gene-specific prim-
ers,  and TAKARA Taq (Takara Bio,  Shiga,  Japan) by a 
Veriti® Thermal Cycler (Applied Biosystems,  Foster 
City,  CA,  USA).  The mRNA expression levels of 
mouse E-selectin (Sele),  mouse P-selectin (Selp),  mouse 
VCAM-1 (Vcam1),  mouse ICAM-1 (Icam1),  mouse 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH;  
Gapdh),  human E-selectin (SELE),  human VCAM-1 
(VCAM1),  human ICAM-1 (ICAM1),  and human 
GAPDH (GAPDH) were measured.  The amplified 
products were electrophoresed in a 1.5% agarose gel 
stained with ethidium bromide.  The gel was imaged 
using a ChemiDocTM Imaging System (Bio-Rad 
Laboratories,  Hercules,  CA,  USA),  and the band 
intensities were analyzed by Image Lab software (Bio-
Rad Labo ratories).  We normalized these measurements 
to those of the constitutively expressed GAPDH gene in 
order to obtain the cell adhesion molecule mRNA lev-
els.  The primer sequences and PCR conditions are 
shown in Table 1.
Western blotting for E- and P-selectin. After the 
culture medium was removed,  the cells were washed 
with ice-cold PBS and resuspended in 200 μL/well cold 
Mammalian Protein Extraction Buffer (GE Healthcare 
Biosciences,  Buckinghamshire,  UK).  This buffer con-
tained 5 mM Na3VO4 (MP Biomedicals,  Santa Ana,  
CA,  USA) and × 1 Protease Inhibitor Cocktail (Sigma 
Chemicals).  The lysates were incubated on ice for 
20 min and then allowed to cool for 15 min at −80°C.  
They were then centrifuged at 141 000g for 30 min at 
4°C to remove cellular debris.  Protein extracts were 
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Table 1　 The primer sequences and PCR conditions used in this study
Primer sequence Annealing (°C)Cycles
Mouse
Sele Forward 5ʼ-GATCCAACGCCAGAACAACA-3ʼ 65°C
Reverse 5ʼ-CCCTTCCACACAGTCAAACG-3ʼ 26 cycles
Selp Forward 5ʼ-CTATACCTGCTCCTGCTACCCAGGC-3ʼ 60°C
Reverse 5ʼ-TTCACTCCACTGACCAGAGCCAGTG-3ʼ 26 cycles
Vcam1 Forward 5ʼ-CAAGGGTGACCAGCTCATGA-3ʼ 55°C
Reverse 5ʼ-TGTGCAGCCACCTGAGATCC-3ʼ 25 cycles
Icam1 Forward 5ʼ-CAACTGGAAGCTGTTTGAGCTG-3ʼ 55°C
Reverse 5'-TAGCTGGAAGATCGAAAGTCCG-3ʼ 29 cycles
Gapdh Forward 5ʼ-TTGGCATTGTGGAAGGGCTCAT-3ʼ 55°C
Reverse 5ʼ-GATGACCTTGCCCACAGCCTT-3ʼ 26 cycles
Human
SELE Forward 5ʼ-CACTCAAGGGCAGTGGACACA-3ʼ 60°C
Reverse 5ʼ-CAGCTGGACCCATAACGGAAAC-3ʼ 20 cycles
VCAM1 Forward 5ʼ-CATGACCTGTTCCAGCGAGG-3ʼ 57°C
Reverse 5ʼ-CATTCACGAGGCCACCACTC-3ʼ 20 cycles
ICAM1 Forward 5ʼ-GGCTGGAGCTGTTTGAGAAC-3ʼ 57°C
Reverse 5ʼ-CCTCTGGCTTCGTCAGAATC-3ʼ 24 cycles
GAPDH Forward 5ʼ-GAAGGTGAAGGTCGGAGTC-3ʼ 57°C
Reverse 5ʼ-GAAGATGGTGATGGGATTTC-3ʼ 26 cycles
The primers were selected from the literature.  The sequences of Selp primers are from Yao et al.  [13].  The sequences of Vcam1 and 
Icam1 primers are from Lindsey et al.  [42].  The sequences of Gapdh primers are from Nacher et al.  [43].  The sequences of SELE and 
VCAM1 primers are from Ito et al.  and Xu et al.,  respectively [44 ,45].  The sequences of ICAM1 and GAPDH primers are from Zhang 
et al.  [46].  The number of ampliﬁcation cycles and annealing temperature for each set was determined experimentally.
quantitated using a Bio-Rad Protein Assay (Bio-Rad 
Laboratories).  Equal amounts of total protein were 
mixed with Laemmli sample buffer (Bio-Rad Labora-
tories),  boiled for 3 min at 100°C,  and cooled on ice.  
Protein samples were separated using sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
in 7.5% acrylamide gels for 2 h at 100 V.  The proteins 
were transferred to polyvinylidene difluoride (PVDF) 
membranes using a Trans-Blot TurboTM Blotting System 
(Bio-Rad Laboratories).  The membranes were washed 
three times with Tween/Tris-buffered salt solution 
(T-TBS) (20 mM Tris-HCl,  pH 7.4,  150 mM NaCl,  
0.1% Tween20; Bio-Rad Laboratories) for 5 min each 
time,  then blocked with T-TBS containing 5% skim 
milk (BD Biosciences,  Lexington,  KY,  USA) for 1 h at 
room temperature.
Afterward blocking,  the membranes were washed 
three times with T-TBS for 5 min each time,  and incu-
bated with one of two primary antibodies overnight at 
4°C: E-selectin,  i.e.,  rat monoclonal anti mouse 
E-selectin/CD62E antibody (R&D Systems,  Minne-
apolis,  MN,  USA) (1 : 2500) or P-selectin,  i.e.,  goat 
polyclonal anti mouse P-selectin/CD62P antibody (R&D 
Systems) (1 : 1000).  After the overnight bath,  the 
membranes were washed and incubated with secondary 
antibodies for 1 h at room temperature: E-selectin,  i.e.,  
peroxidase-labeled goat antibody to rat IgG (H + L) 
(Kirkegaard & Perry Laboratories,  Gaithersburg,  MD,  
USA) (1 : 5000),  or P-selectin,  i.e.,  peroxidase-labeled 
rabbit antibody to goat IgG (H + L) (Kirkegaard & Perry 
Laboratories) (1 : 5000).  The membranes were washed 
three times with T-TBS for 5 min each time.  Protein 
detection was performed using an Amersham ECL 
Prime Western Blotting Detection Kit (GE Healthcare 
Biosciences).
Blots were imaged using the ChemiDoc system,  and 
proteins were quantitated using the Image Lab software.  
Blots were stripped using RestoreTM PLUS Western Blot 
Stripping Buffer (Thermo Fisher Scientific,  Waltham,  
MA,  USA) for 15 min at 37°C and redetected with rab-
bit anti-actin antibody (Sigma Chemical) (1 : 1000),  
followed by peroxidase-labeled goat anti rabbit IgG 
(H + L) (Kirkegaard & Perry Laboratories) (1 : 10000) as 
an internal control.  E- and P-selectin band intensities 
were normalized to actin band intensities.
Preparation of cytoplasm and nucleus,  and NF-κB 
detection. The bEnd.3 cells were incubated in the 
absence or presence of 0.01% Lvn,  125 μM LA,  or 
250 μM LO for 2 h.  Next,  the cells were stimulated by 
murine TNF-α (250 U/mL) for up to 10,  30,  or 60 min.  
Corresponding volumes of PBS were added to control 
cultures.  After the TNF-α stimulation step,  viable cell 
suspensions were separated into nuclear protein lysates 
and cytoplasmic lysates using NE-PER® Nuclear and 
Cytoplasmic Extraction Reagents (Thermo Fisher 
Scientific),  according to the manufacturer’s protocol.  
As a protease inhibitor,  0.5 mM of phenylmethylsulfo-
nyl fluoride (PMSF) (Sigma Chemical) was added.  
Nuclear and cytoplasmic protein extracts were quanti-
tated using the Bio-Rad Protein Assay.
To determine whether Lvn,  LA,  and LO affected the 
activation of NF-κB,  we performed western blotting for 
phosphorylated-NF-κB p65 in the nucleus and NF-κB 
p65 in the cytoplasm.  Constant amounts of nuclear or 
cytoplasmic protein extracts were electrophoresed using 
SDS-PAGE,  and western blotting was performed.  As 
the primary antibody,  rabbit anti-NF-κB p65 antibody 
(Cell Signaling Technology,  Danvers,  MA,  USA) 
(1 : 1000) was used in cytoplasmic blots and rabbit anti-
phospho-NF-κB p65 antibody (Cell Signaling 
Technology) (1 : 1000) was used in nuclear blots.  As the 
secondary antibody,  peroxidase-labeled goat anti rabbit 
IgG (H + L) (Kirkegaard & Perry Laboratories) 
(1 : 5000) was used.  Actin was used as an internal con-
trol in the cytoplasm extracts.
Statistical analysis. The statistical analysis was 
performed with GraphPad Prism ver. 6.01 (GraphPad 
Software,  La Jolla,  CA,  USA).  The data are expressed 
as the mean ± SEM of at least three independent exper-
iments.  We used an analysis of variance (ANOVA) with 
Tukey’s post-hoc test for multiple comparisons to assess 
statistical significance.  Probability values < 0.05 were 
considered significant.
Results
Lvn inhibited the TNF-α-induced E-selectin, 
P-selectin,  VCAM-1,  and ICAM-1 expression in bEnd.3 
cells. We used RT-PCR to measure the expression 
levels of Sele,  Selp,  Vcam1,  and Icam1 in bEnd.3 cells 
(Fig. 1A-D).  The mRNA expression levels of the cell 
adhesion molecules showed significant increases after 
TNF-α stimulation (lane 2).  In the 0.01% Lvn-treated 
cells (lane 5),  the TNF-α-induced expression levels of 
Sele,  Vcam1,  and Icam1 were significantly lower than 
those of the TNF-α-stimulated cells (p < 0.05,  p < 0.01,  
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and p < 0.05,  respectively).  The TNF-α-induced Selp 
expression was not significantly inhibited.  In the 
0.005% Lvn-treated cells (lane 6),  the TNF-α-induced 
expressions of Sele,  Selp,  Vcam1,  and Icam1 were not 
inhibited.
The expression levels of E- and P-selectin in bEnd.3 
cells were measured by western blotting.  As shown in 
Fig. 1E , F,  the expression levels of E- and P-selectin 
were significantly elevated in the TNF-α-stimulated 
cells (lane 2).  The TNF-α-induced E-selectin (lane 5,  
p < 0.001; lane 6,  p < 0.05) and P-selectin (lanes 5 and 6,  
p < 0.05 for both comparisons) expression levels were 
significantly lower in the Lvn-treated cells compared to 
those in TNF-α-stimulated cells.
Lvn inhibited TNF-α-induced NF-κB activation in 
bEnd.3 cells. To determine whether Lvn inhibits 
NF-κB activation,  we performed western blotting for 
phosphorylated-NF-κB p65 in the nuclear extract and 
NF-κB p65 in the cytoplasmic extract (Fig. 2).  The 
phosphorylated-NF-κB p65 in the nucleus was signifi-
cantly increased in TNF-α-stimulated cells at 10,  30,  
and 60 min (lane 2,  p < 0.05; lane 3,  p < 0.001; lane 4,  
p < 0.05).  The highest activation of NF-κB p65 was 
observed at 30 min after TNF-α stimulation.
Lvn significantly suppressed phosphorylated-NF-κB 
p65 in the nucleus at 30 min (lane 6,  p < 0.05) and 
60 min (lane 7,  p < 0.05) after TNF-α stimulation.  No 
significant differences in cytoplasmic NF-κB p65 were 
observed in any lane.
LA and LO inhibited the TNF-α-induced mRNA 
expression of cell adhesion molecules in bEnd.3 cells.
At 0.01%,  Lvn inhibited the expression levels of TNF-
α-induced cell adhesion molecules which contained 
approx.  136 μM of LA and 142 μM of LO.  We con-
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Fig. 1　 Eﬀects of Lvn on TNF-α-induced E-selectin,  P-selectin,  VCAM-1,  and ICAM-1 expression in bEnd.3 cells.  The expression levels 
of Sele (A),  Selp (B),  Vcam1 (C),  and Icam1 (D) were quantiﬁed by RT-PCR.  Gapdh was used as an internal control.  The E-selectin 
(E) and P-selectin (F) were measured by western blotting.  Actin was used as an internal control.  The cells were pretreated with or without 
0.01% or 0.005% Lvn for 2 h.  The total RNA (A-D) and the cell lysates (E ,F) were prepared from bEnd.3 cells incubated in the presence 
or absence of 250 U/mL murine TNF-α for 3 or 5 h.  ＃p＜0.05 and ＃＃＃p＜0.001 vs. non-stimulated cells; ＊p＜0.05,  ＊＊p＜0.01,  and 
＊＊＊p＜0.001 vs. TNF-α-stimulated cells.
firmed that these concentrations of LA and LO did not 
exhibit cytotoxicity to bEnd.3 cells by MTT assay (data 
not shown).  To determine the effects of LA on the 
TNF-α-induced Sele,  Selp,  Vcam1,  and Icam1 expres-
sion levels,  we incubated bEnd.3 cells in the absence or 
presence of each of two LA concentrations (125 or 
62.5 μM).  As shown in Fig. 3A-D,  the mRNA expres-
sion levels of the cell adhesion molecules were signifi-
cantly increased by the TNF-α stimulation (lane 2).  LA 
inhibited the TNF-α-induced expression levels of Sele 
(p < 0.01),  Selp (p < 0.01),  and Vcam1 (p < 0.05) at 125 
and 62.5 μM (lanes 5 and 6) relative to TNF-α-stimu-
lated cells.  LA also inhibited the TNF-α-induced Icam1 
expression at 125 μM (lane 5,  p < 0.01) relative to the 
TNF-α-stimulated cells.
We also analyzed the effects of LO on the TNF-α-
induced mRNA expression levels of cell adhesion mole-
cules.  The bEnd.3 cells were incubated in the absence or 
presence of each of two LO concentrations (250 or 
125 μM).  As shown in Fig. 3E-H,  in the presence of 
250 μM LO,  the TNF-α-induced mRNA expression 
levels were inhibited for Sele,  Vcam1,  and Icam1 (lane 
5,  p < 0.05,  p < 0.001,  and p < 0.01,  respectively) relative 
to the TNF-α-stimulated cells (lane 2).  In the presence 
of 125 μM LO,  the TNF-α-induced mRNA expression 
levels were inhibited for Sele and Vcam1 (lane 6,  p < 0.05 
and p < 0.01,  respectively) relative to the TNF-α-
stimulated cells.  However,  LO did not inhibit the TNF-
α-induced Selp expression (Fig. 3F).
LA inhibited the TNF-α-induced NF-κB activation 
in bEnd.3 cells. To determine whether LA or LO 
inhibits NF-κB activation in bEnd.3 cells,  we per-
formed western blotting for phosphorylated-NF-κB p65 
in the nucleus (Fig. 4).  The phosphorylated-NF-κB p65 
was significantly increased by TNF-α stimulation at 30 
and 60 min (Fig. 4A , B,  lane 2,  p < 0.01,  both; lane 3,  
p < 0.001,  both) relative to the non-stimulated cells 
(lane 1).  The highest activation of NF-κB p65 was 
observed at 60 min after TNF-α stimulation.  In the 
LA-treated cells,  the phosphorylated-NF-κB p65 in the 
nucleus was significantly suppressed at 60 min after 
TNF-α stimulation (Fig. 4A,  lane 5,  p < 0.01).  LO did 
not significantly suppress the TNF-α-induced phos-
phorylated-NF-κB p65 in the nucleus (Fig. 4B).  These 
results indicate that compared to LO,  LA more potently 
inhibited the TNF-α-induced expression levels of cell 
adhesion molecules through a suppression of NF-κB 
activation.
Lvn inhibited the TNF-α-induced E-selectin mRNA 
expression in HUVECs. We also examined the effects 
of Lvn on the TNF-α-induced expression levels of SELE,  
VCAM1,  and ICAM1 in HUVECs (Fig. 5).  The expres-
sion levels of SELE,  VCAM1,  and ICAM1 were signifi-
cantly increased by TNF-α stimulation (lane 2).  At 
0.01% and 0.005%,  Lvn inhibited TNF-α-induced 
E-selectin mRNA expression (Fig. 5A,  lane 5,  p < 0.001;  
lane 6,  p < 0.01) relative to the TNF-α-stimulated cells.  
However,  Lvn did not inhibit the TNF-α-induced 
mRNA expression of VCAM1 or ICAM1 (Fig. 5B, C).
Discussion
Essential oils are used for various symptoms of not 
only illness but also mood and emotion.  Here we veri-
fied the anti-inflammatory effects of Lvn and its main 
constituents,  LA and LO,  on cell adhesion molecules in 
endothelial cells.
The expression of cell adhesion molecules in endo-
thelial cells plays a key role in recruiting leukocytes and 
initiating inflammation [18].  The curdlan-induced 
accumulation of neutrophils and myeloperoxidase 
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Fig. 2　 Eﬀects of Lvn on NF-κB activation in bEnd.3 cells stimu-
lated with TNF-α.  The nuclear phosphorylated-NF-κB p65 and the 
cytoplasmic NF-κB p65 were measured by western blotting.  Actin 
was used as an internal control.  The cells were stimulated by 
250 U/mL murine TNF-α after treatment with 0.01% Lvn for 2 h.  
＃p＜0.05 and ＃＃＃p＜0.001 vs. non-stimulated cells; ＊p＜0.05 vs. 
TNF-α-stimulated cells; n.s.,  not signiﬁcant.
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Fig. 3　 Eﬀects of LA and LO on TNF-α-induced E-selectin,  P-selectin,  VCAM-1,  and ICAM-1 mRNA expression in bEnd.3 cells.  The 
expression levels of Sele (A ,E),  Selp (B ,F),  Vcam1 (C ,G),  and Icam1 (D ,H) were quantiﬁed by RT-PCR.  Gapdh was used as an 
internal control.  The cells were stimulated with 250 U/mL murine TNF-α after treatment with LA or LO for 2 h.  ＃p＜0.05 and ＃＃＃p＜
0.001 vs. non-stimulated cells; ＊p＜0.05,  ＊＊p＜0.01,  and ＊＊＊p＜0.001 vs. TNF-α-stimulated cells.
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Fig. 4　 Eﬀects of LA and LO on NF-κB activation in bEnd.3 cells stimulated with TNF-α.  The cells were treated with or without 125 µM 
LA (A) and with or without 250 µM LO (B),  for 2 h,  and stimulated with 250 U/mL murine TNF-α.  The phosphorylated-NF-κB p65 in the 
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Fig. 5　 Eﬀects of Lvn on the mRNA expression of TNF-α-induced E-selectin,  
VCAM-1,  and ICAM-1 in HUVECs.  The expression levels of SELE (A),  
VCAM1 (B),  and ICAM1 (C) in HUVECs were quantiﬁed by RT-PCR.  
GAPDH was used as an internal control.  The cells were stimulated with 
100 U/mL human TNF-α after being treated with 0.01% or 0.005% Lvn for 2 h.  
＃p＜0.05 and ＃＃＃p＜0.001 vs. non-stimulated cells; ＊＊p＜0.01 and ＊＊＊p＜
0.001 vs. TNF-α-stimulated cells.
activity of skin lesions are suppressed dose-dependently 
by the cutaneous application of essential oils such as 
Pelargonium asperum,  Lavandula angustifolia (Lvn),  
Eucalyptus globulus,  and Melaleuca alternifolia [23].  
TNF-α-induced cell adhesion molecules on vascular 
endothelial cells promote the transmigration of leuko-
cytes into the tissues,  thereby causing inflammation.
To the best of our knowledge,  there are no previous 
reports that Lvn and LA inhibit TNF-α-induced cell 
adhesion molecules in endothelial cells.  In bEnd.3 cells,  
we observed that Lvn inhibited the TNF-α-induced 
mRNA expression levels of E-selectin,  VCAM-1,  and 
ICAM-1,  in a dose-dependent manner.  Although Lvn 
did not inhibit the TNF-α-induced P-selectin mRNA 
expression,  western blotting revealed that Lvn inhibited 
the TNF-α-induced E- and P-selectin expression levels.  
As E- and P-selectin are involved in the adhesion of 
granulocytes to vascular endothelial cells,  Lvn may 
inhibit the adhesion of granulocytes to the vascular 
endothelium through the suppression of both selectins 
[24].  Moreover,  adherent leukocytes induce the clus-
tering of ICAM-1 or VCAM-1 on the surface of endo-
thelial cells,  and the dissociation of the vascular endo-
thelial protein tyrosine phosphatase/VE-cadherin 
complex is implicated in endothelial cell-to-cell adhe-
sion,  leading to their enhanced transmigration into the 
underlying tissues [25 , 26].  Thus,  the inhibition of the 
expression of these cell adhesion molecules by treat-
ment with Lvn or its constituents may have a significant 
impact on the alleviation of inflammation symptoms 
through the suppression of leukocyte adhesion on 
endothelial cells and transmigration across the endo-
thelium.
The NF-κB family of transcription factors includes 
p50,  p52,  p65 (RelA),  c-Rel,  and RelB [27].  NF-κB 
p65 plays an important role in the expression of cell 
adhesion molecules in endothelial cells.  NF-κB p50/p65 
heterodimer binds to the NF-κB binding sites of 
E-selectin [28],  VCAM-1 [29],  and ICAM-1 genes [30].  
In murine P-selectin gene,  the p50/p65 heterodimer 
and p65 homodimer bind to the NF-κB response ele-
ments [31].  The activity of NF-κB is regulated by its 
interaction with the inhibitory protein IκBα in the cyto-
plasm [27].  The canonical NF-κB pathway is activated 
through proinflammatory receptors such as the TNF 
receptor,  Toll-like receptor,  and cytokine receptors for 
the interleukins [27 , 32].  TNF-α or other cytokines 
activate this pathway,  cause the phosphorylation and 
ubiquitination of IκBα,  and allow the nuclear translo-
cation of NF-κB p50/p65 heterodimer and subsequent 
DNA binding.
In the present study,  Lvn inhibited TNF-α-induced 
E-selectin,  P-selectin,  VCAM-1,  and ICAM-1 expres-
sion in bEnd.3 cells,  and suppressed the TNF-α-
induced phosphorylated-NF-κB p65 in the nucleus.  
These results show that the suppression of NF-κB acti-
vation by Lvn may be involved in the inhibition of 
TNF-α-induced cell adhesion molecules,  such as 
E-selectin,  P-selectin,  VCAM-1,  and ICAM-1 in bEnd.3 
cells.
LA is the acetate ester of LO [33] and a main con-
stituent of many essential oils from herbal plants such as 
lavender [9],  bergamot [34],  and clary sage [35].  The 
cytotoxicity of LA is higher than that of Lvn in human 
dermal microvascular endothelial cells and fibroblasts 
[36].  LA in combination with terpeniol and camphor 
was also reported to be effective against a human colon 
cancer cell line [37].  In our study,  LA inhibited the 
TNF-α-induced mRNA expression of E-selectin,  
P-selectin,  VCAM-1,  and ICAM-1 in bEnd.3 cells (a 
murine brain endothelial cell line),  and it suppressed 
phosphorylated-NF-κB p65 in the nucleus.  LO inhib-
ited the TNF-α-induced mRNA expression of 
E-selectin,  VCAM-1,  and ICAM-1 in bEnd. 3 cells,  but 
it did not significantly suppress the TNF-α-induced 
P-selectin mRNA expression or phosphorylated-NF-κB 
p65 in the nucleus.  These results suggest that Lvn has 
anti-inflammatory effects via the suppression of NF-κB 
activation because of its LA as a main constituent.
The inhibition of TNF-α-induced cell adhesion mol-
ecules by Lvn would lessen the attachment of leukocytes 
to inflammatory sites,  potentially exerting anti-inflam-
matory effects.  Our present findings thus suggest a part 
of the mechanism underlying the anti-inflammatory 
effects of Lvn,  and further studies are necessary to 
reveal other effects of essential oils.  Our model for the 
roles of LA in Lvn’s anti-inflammatory effects might be 
relevant to the effects of other essential oils that include 
LA.
We also observed that in the HUVECs,  Lvn inhib-
ited the TNF-α-induced E-selectin mRNA expression,  
but it did not inhibit TNF-α-induced VCAM-1 or 
ICAM-1 mRNA expression.  P-selectin mRNA expres-
sion was not increased by TNF-α stimulation in 
HUVECs (data not shown) because TNF-α does not 
have the ability to activate the human P-selectin gene 
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[13 , 38].  There are three NF-κB binding sites in the 
human E-selectin gene; these binding sites are neces-
sary for the maximal E-selectin induction of TNF-α 
stimulation [28].  Two NF-κB binding sites,  a single 
GATA binding site,  and a single interferon regulatory 
factor-1 binding site are necessary for TNF-α-induced 
human VCAM-1 expression [29 , 39].  The TNF-α 
response elements consist of single NF-κB and CCAAT/
enhancer binding protein binding sites in human 
ICAM-1 gene [30 , 40 , 41].  The different actions of Lvn 
on TNF-α-induced cell adhesion molecules in HUVECs 
may be caused by the number of NF-κB binding sites 
and the relations of other transcription factors.
Given this situation,  the three NF-κB binding sites 
of human E-selectin gene might provide high sensitivity 
to Lvn’s effects.  However,  in murine bEnd.3 cells,  Lvn 
inhibited four types of TNF-α-induced cell adhesion 
molecules.  The activation system of transcription fac-
tors may differ between mice and humans.
In conclusion,  our data suggest that Lvn and LA 
inhibit the TNF-α-induced expression of cell adhesion 
molecules in vascular endothelial cells through a sup-
pression of the activation of NF-κB.  Therefore,  essen-
tial oils containing LA as a main constituent might exert 
anti-inflammatory activity.
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